Copyright
©The Author(s) 2021.
World J Gastroenterol. Mar 7, 2021; 27(9): 866-885
Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.866
Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.866
Figure 1 Serum beta-glucan concentrations in patients with Crohn’s disease, ulcerative colitis, and controls.
The analysis was performed by the Kruskal-Wallis on ranks test, in which multiple comparisons were performed using Dunn’s test. The horizontal bars represent the medians, and the boxes represent the 25th and 75th percentiles. Significant results are depicted (aP < 0.0001).
- Citation: Farias e Silva K, Nanini HF, Cascabulho CM, Rosas SLB, Santana PT, Carneiro AJV, Anaissie E, Nucci M, de Souza HSP. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(9): 866-885
- URL: https://www.wjgnet.com/1007-9327/full/v27/i9/866.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i9.866